MedPath

FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS

🇮🇹Italy
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

775

Active:71
Completed:184

Trial Phases

6 Phases

Early Phase 1:2
Phase 1:10
Phase 2:25
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (329 trials with phase data)• Click on a phase to view related trials

Not Applicable
261 (79.3%)
Phase 2
25 (7.6%)
Phase 4
18 (5.5%)
Phase 3
12 (3.6%)
Phase 1
10 (3.0%)
Early Phase 1
2 (0.6%)
phase_1_2
1 (0.3%)

Anderson Fabry Disease - the Power of Information.

Not Applicable
Completed
Conditions
Fabry Disease
First Posted Date
2025-08-22
Last Posted Date
2025-08-22
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Target Recruit Count
20
Registration Number
NCT07136662
Locations
🇮🇹

Fondazione Policlinico Gemelli IRCCS, Roma, RM, Italy

Health Oriented Protocol for Epidermal Radiodermatitis

Not yet recruiting
Conditions
Head and Neck Cancer
Gynecologic Cancer
Pelvic Cancer
Radiation Skin Injury
Radiotherapy Side Effect
First Posted Date
2025-08-19
Last Posted Date
2025-08-19
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Target Recruit Count
80
Registration Number
NCT07129525

2D-shear Wave Spleen Elastography in Clinically Significant Portal Hypertension and High-risk Varices

Not yet recruiting
Conditions
Portal Hypertension Related to Cirrhosis
Esophageal Varices
First Posted Date
2025-08-14
Last Posted Date
2025-08-14
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Target Recruit Count
450
Registration Number
NCT07122622

Aortic Dissection fAlse enlarGement radIomics predictiOn

Active, not recruiting
Conditions
Dissection
Aortic Diseases
Aortic Dissection
First Posted Date
2025-08-12
Last Posted Date
2025-08-12
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Target Recruit Count
500
Registration Number
NCT07117825
Locations
🇮🇹

Giovanni Tinelli, Roma, Italy

O2 Consumption And CO2 Production After Hemodynamic Optimization In Shock

Recruiting
Conditions
Hemodynamic Instability
Oxygen Consumption (V̇O2)
First Posted Date
2025-08-06
Last Posted Date
2025-08-06
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Target Recruit Count
36
Registration Number
NCT07107724
Locations
🇮🇹

Policlinico Universitario Fondazione Agostino Gemelli IRCCS, Roma, Italy

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 152
  • Next

News

EndoZip™ Automated Endoscopic System Shows 11.4% Weight Loss and Improved Comorbidities in Obesity Trial

Interim clinical data from the EndoZip™ automated endoscopic suturing system demonstrated an average total body weight loss of 11.4% at twelve months in patients with class I and II obesity.

Secure Multiparty Computation Enables Privacy-Friendly Evaluation of Patient Data in Adrenal Gland Metastasis Study

A bicenter, prospective, longitudinal observational study utilized MR-guided radiotherapy (MRgRT) to treat adrenal gland metastasis, emphasizing precision and minimizing radiation exposure.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.